{"prompt": "['to 1.5 X baseline; >', 'per study protocol.', 'ULN to 1.5 X ULN)', 'If creatinine worsens, depending on the severity, treat as', 'Grade 2, 3, or 4.', '-', 'Consider symptomatic treatment, including hydration, electrolyte', 'replacement, and diuretics.', 'Grade 2', 'Hold study drug/study regimen until', 'For Grade 2:', '(serum creatinine >1.5', 'resolution to Grade 1 or baseline.', '-', 'Consider symptomatic treatment, including hydration, electrolyte', 'to 3.0 X baseline; >1.5', 'If toxicity worsens, then treat as', 'replacement, and diuretics.', 'Grade 3 or 4.', '-', 'Carefully monitor serum creatinine every 2 to 3 days and as clinically', 'to 3.0 X ULN)', 'warranted.', 'If toxicity improves to Grade 1 or', 'baseline, then resume study', '-', 'Consult nephrologist and consider renal biopsy if clinically indicated.', 'drug/study regimen after completion', '-', 'If event is persistent (>3 to 5 days) or worsens, promptly start', 'of steroid taper.', 'prednisone 1 to 2 mg/kg/day PO or IV equivalent.', '-', 'If event is not responsive within 3 to 5 days or worsens despite', 'prednisone at 1 to 2 mg/kg/day PO or IV equivalent, additional workup', 'should be considered and prompt treatment with IV methylprednisolone', 'at 2 to 4 mg/kg/day started.', '-', 'Once the patient is improving, gradually taper steroids over >28 days', 'and consider prophylactic antibiotics, antifungals, and anti-PJP', 'treatment (refer to current NCCN guidelines for treatment of cancer-', 'related infections [Category 2B recommendation].', '-', 'When event returns to baseline, resume study drug/study regimen and', 'routine serum creatinine monitoring per study protocol.', 'Grade 3 or 4', 'Permanently discontinue study drug/study', 'For Grade 3 or 4:', 'regimen.', '-', '(Grade 3: serum', 'Carefully monitor serum creatinine on daily basis.', '-', 'creatinine', 'Consult nephrologist and consider renal biopsy if clinically indicated.', '-', '>3.0 X baseline; >3.0 to', 'Promptly start prednisone 1 to 2 mg/kg/day PO or IV equivalent.', '-', 'If event is not responsive within 3 to 5 days or worsens despite', '6.0 X ULN;', 'prednisone at 1 to 2 mg/kg/day PO or IV equivalent, additional workup', 'should be considered and prompt treatment with IV methylprednisolone', '2 to 4 mg/kg/day started.', 'Grade 4: serum', '-', 'Once the patient is improving, gradually taper steroids over >28 days', 'creatinine >6.0 X ULN)', 'and consider prophylactic antibiotics, antifungals, and anti-PJP', 'treatment (refer to current NCCN guidelines for treatment of cancer-', 'related infections [Category 2B recommendation]).', 'Rash', 'Any Grade', 'General Guidance', 'For Any Grade:', '-', '(excluding bullous skin formations)', '(refer to NCI CTCAE', 'Monitor for signs and symptoms of dermatitis (rash and pruritus).', '-', 'V 4.03 for definition of', 'IF THERE IS ANY BULLOUS FORMATION, THE STUDY', 'PRODIGE 59 - DURIGAST -', 'Version 2.0 - 04.08.2020 ENG', 'Page 99 de 123']['PHYSICIAN SHOULD BE CONTACTED AND STUDY DRUG', 'severity/grade', 'DISCONTINUED.', 'depending on type of', 'skin rash)', 'Grade 1', 'No dose modifications.', 'For Grade 1:', '-', 'Consider symptomatic treatment, including oral antipruritics (e.g.,', 'diphenhydramine or hydroxyzine) and topical therapy (e.g., urea', 'cream).', 'Grade 2', 'For persistent (>1 to 2 weeks) Grade 2', 'For Grade 2:', 'events, hold scheduled study drug/study', '-', 'Obtain dermatology consult.', 'regimen until resolution to Grade 1 or', '-', 'Consider symptomatic treatment, including oral antipruritics (e.g.,', 'baseline.', 'diphenhydramine or hydroxyzine) and topical therapy (e.g., urea', 'cream).', 'If toxicity worsens, then treat as', '-', 'Consider moderate-strength topical steroid.', 'Grade 3.', '-', 'If no improvement of rash/skin lesions occurs within 3 to 5 days or is', 'If toxicity improves to Grade <1 or', 'worsening despite symptomatic treatment and/or use of moderate', 'baseline, then resume drug/study', 'strength topical steroid, consider, as necessary, discussing with study', 'regimen after completion of steroid', 'physician and promptly start systemic steroids such as prednisone 1 to 2', 'taper.', 'mg/kg/day PO or IV equivalent.', '-', 'Consider skin biopsy if the event is persistent for >1 to 2 weeks or', 'recurs.', 'Grade 3 or 4', 'For Grade 3:', 'For Grade 3 or 4:', '-', 'Hold study drug/study regimen until', 'Consult dermatology.', '-', 'resolution to Grade 1 or baseline.', 'Promptly initiate empiric IV methylprednisolone 1 to 4 mg/kg/day or', 'equivalent.', 'If temporarily holding the study', '-', 'Consider hospitalization.', 'drug/study regimen does not provide', '-', 'Monitor extent of rash [Rule of Nines].', 'improvement of the Grade 3 skin rash to', '-', 'Consider skin biopsy (preferably more than 1) as clinically feasible.', 'Grade 1 or baseline within 30 days, then', '-', 'Once the patient is improving, gradually taper steroids over >28 days', 'permanently discontinue study drug/study', 'and consider prophylactic antibiotics, antifungals, and anti-PJP', 'treatment (refer to current NCCN guidelines for treatment of cancer-', 'regimen.', 'related infections [Category 2B recommendation].\u00b0', '-', 'Consider, as necessary, discussing with study physician.', 'For Grade 4:', 'Permanently discontinue study drug/study', 'regimen.', 'PRODIGE 59 - DURIGAST -', 'Version 2.0 - 04.08.2020 ENG', 'Page 100 de 123']\n\n###\n\n", "completion": "END"}